HIV-induced Immunodeficiency and Mortality from AIDS-defining and Non-AIDS-defining Malignancies

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2008 Oct 4

PMID 18832878

Citations 97

Authors

Antonella dArminio Monforte

Donald Abrams

Christian Pradier

Rainer Weber

Peter Reiss

Fabrice Bonnet

Ole Kirk

Matthew Law

Stephane De Wit

Nina Friis-Moller

Andrew N Phillips

Caroline A Sabin

Jens D Lundgren

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate deaths from AIDS-defining malignancies (ADM) and non-AIDS-defining malignancies (nADM) in the D:A:D Study and to investigate the relationship between these deaths and immunodeficiency.

Design: Observational cohort study.

Methods: Patients (23 437) were followed prospectively for 104 921 person-years. We used Poisson regression models to identify factors independently associated with deaths from ADM and nADM. Analyses of factors associated with mortality due to nADM were repeated after excluding nADM known to be associated with a specific risk factor.

Results: Three hundred five patients died due to a malignancy, 298 prior to the cutoff for this analysis (ADM: n = 110; nADM: n = 188). The mortality rate due to ADM decreased from 20.1/1000 person-years of follow-up [95% confidence interval (CI) 14.4, 25.9] when the most recent CD4 cell count was <50 cells/microl to 0.1 (0.03, 0.3)/1000 person-years of follow-up when the CD4 cell count was more than 500 cells/microl; the mortality rate from nADM decreased from 6.0 (95% CI 3.3, 10.1) to 0.6 (0.4, 0.8) per 1000 person-years of follow-up between these two CD4 cell count strata. In multivariable regression analyses, a two-fold higher latest CD4 cell count was associated with a halving of the risk of ADM mortality. Other predictors of an increased risk of ADM mortality were homosexual risk group, older age, a previous (non-malignancy) AIDS diagnosis and earlier calendar years. Predictors of an increased risk of nADM mortality included lower CD4 cell count, older age, current/ex-smoking status, longer cumulative exposure to combination antiretroviral therapy, active hepatitis B infection and earlier calendar year.

Conclusion: The severity of immunosuppression is predictive of death from both ADM and nADM in HIV-infected populations.

Citing Articles

Interventions for tobacco use cessation in people living with HIV.

Mdege N, Shah S, Dogar O, Pool E, Weatherburn P, Siddiqi K Cochrane Database Syst Rev. 2024; 8:CD011120.

PMID: 39101506 PMC: 11299227. DOI: 10.1002/14651858.CD011120.pub3.

Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up.

Suarez-Garcia I, Gutierrez F, Perez-Molina J, Moreno S, Aldamiz T, Valencia Ortega E J Cancer Res Clin Oncol. 2023; 149(20):18161-18171.

PMID: 38008809 PMC: 10725373. DOI: 10.1007/s00432-023-05500-9.

Systems crosstalk between antiviral response and cancerous pathways via extracellular vesicles in HIV-1-associated colorectal cancer.

Chen Z, Yang K, Zhang J, Ren S, Chen H, Guo J Comput Struct Biotechnol J. 2023; 21:3369-3382.

PMID: 37389186 PMC: 10300105. DOI: 10.1016/j.csbj.2023.06.010.

Single-cell sequencing resolves the landscape of immune cells and regulatory mechanisms in HIV-infected immune non-responders.

Li H, Tang Y, Wang Y, Li Y, Yang Y, Liao K Cell Death Dis. 2022; 13(10):849.

PMID: 36195585 PMC: 9532384. DOI: 10.1038/s41419-022-05225-6.

Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer.

Yang J, Wei G, Gui F, Zhao Y, Chen T, Tan J AIDS Res Ther. 2022; 19(1):45.

PMID: 36151562 PMC: 9508721. DOI: 10.1186/s12981-022-00470-3.

References

Bestilny L, Gill M, Mody C, Riabowol K . Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS. 2000; 14(7):771-80. DOI: 10.1097/00002030-200005050-00002. View

Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F . Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005; 42(6):799-805. DOI: 10.1016/j.jhep.2005.01.022. View

Olivero O, Tejera A, Fernandez J, Taylor B, Das S, Divi R . Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005; 20(2):139-46. DOI: 10.1093/mutage/gei019. View

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

Allardice G, Hole D, Brewster D, Boyd J, Goldberg D . Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer. 2003; 89(3):505-7. PMC: 2394375. DOI: 10.1038/sj.bjc.6601139. View

Mocroft A, Brettle R, Kirk O, Blaxhult A, PARKIN J, Antunes F . Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002; 16(12):1663-71. DOI: 10.1097/00002030-200208160-00012. View

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace M, Spooner K . Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005; 104(7):1505-11. DOI: 10.1002/cncr.21334. View

Carr A, Cooper D . Adverse effects of antiretroviral therapy. Lancet. 2000; 356(9239):1423-30. DOI: 10.1016/S0140-6736(00)02854-3. View

Murillas J, Del Rio M, Riera M, Vaquer P, Salas A, Leyes M . Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients. Eur J Intern Med. 2005; 16(2):113-115. DOI: 10.1016/j.ejim.2004.09.011. View

10.

Patel P, Hanson D, Sullivan P, Novak R, Moorman A, Tong T . Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148(10):728-36. DOI: 10.7326/0003-4819-148-10-200805200-00005. View

11.

Sackoff J, Hanna D, Pfeiffer M, Torian L . Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006; 145(6):397-406. DOI: 10.7326/0003-4819-145-6-200609190-00003. View

12.

Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C . Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003; 21(18):3447-53. DOI: 10.1200/JCO.2003.01.096. View

13.

Frisch M, Biggar R, Engels E, Goedert J . Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001; 285(13):1736-45. DOI: 10.1001/jama.285.13.1736. View

14.

Clifford G, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A . Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005; 97(6):425-32. DOI: 10.1093/jnci/dji072. View

15.

Kirk G, Merlo C, O Driscoll P, Mehta S, Galai N, Vlahov D . HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007; 45(1):103-10. PMC: 4078722. DOI: 10.1086/518606. View

16.

Merchante N, Giron-Gonzalez J, Gonzalez-Serrano M, Torre-Cisneros J, Garcia-Garcia J, Arizcorreta A . Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 2005; 20(1):49-57. DOI: 10.1097/01.aids.0000198087.47454.e1. View

17.

Grulich A, van Leeuwen M, Falster M, Vajdic C . Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370(9581):59-67. DOI: 10.1016/S0140-6736(07)61050-2. View

18.

Engels E, Pfeiffer R, Goedert J, Virgo P, McNeel T, Scoppa S . Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006; 20(12):1645-54. DOI: 10.1097/01.aids.0000238411.75324.59. View

19.

Weber R, Sabin C, Friis-Moller N, Reiss P, El-Sadr W, Kirk O . Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006; 166(15):1632-41. DOI: 10.1001/archinte.166.15.1632. View

20.

Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F . Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2004; 34(1):121-30. DOI: 10.1093/ije/dyh307. View